(S)-Tert-Butyl 3-(Hydroxymethyl)Pyrrolidine-1-Carboxylate

(S)-tert-Butyl 3-(hydroxymethyl)pyrrolidine-1-carboxylate is supplied as a white to off-white crystalline powder with a molecular formula C10H19NO3, molecular weight 201.26 g/mol, and CAS registry number 199174-24-8. The compound serves as an N-Boc-protected chiral pyrrolidine building block, where the (S)-configuration at the 3-position of the heterocycle defines the stereochemical outcome of downstream transformations in medicinal chemistry and process-scale API synthesis. Typical production batches assay at ≥98.0% chemical purity by reversed-phase HPLC (UV detection at 210 nm) and ≥99.0% enantiomeric excess (ee) by chiral HPLC on a Chiralpak IA-3 column (250 × 4.6 mm, 3 µm) with an n-hexane/2-propanol mobile phase at 1.0 mL/min. Residual water content by Karl Fischer coulometric titration is controlled to ≤0.5%, and residual solvents—typically ethyl acetate and n-heptane from the recrystallization train—are monitored by headspace GC-FID against ICH Q3C limit concentrations.

What optical rotation ranges are routinely encountered across pilot-plant lots manufactured via enzymatic resolution?

Production-scale access to the single enantiomer frequently relies on lipase-catalyzed kinetic resolution of the racemic acetate ester in phosphate buffer at pH 7.2 and 37 °C, using immobilized Candida antarctica lipase B (CALB) on a macroporous acrylic resin with a particle size distribution of 300–500 µm. Under these conditions, the measured specific rotation [α]D20 (c = 1.0, methanol) for the isolated (S)-alcohol falls consistently within −28.0° to −31.0°. Lot-to-lot drift beyond this window has been traced to incomplete removal of the corresponding (R)-acetate, which co-crystallizes at levels below 0.5% yet depresses the specific rotation by 0.8–1.2° per 0.1% contamination. On a 500 L jacketed glass-lined reactor equipped with pitched-blade impeller agitation at 120 rpm, resolution campaigns exceeding 80 kg input racemate yield the (S)-enantiomer with an average ee of 99.4% and a chemical purity of 99.1% after a single reslurry in methyl tert-butyl ether at −5 °C.

Thermal and hydrolytic stability boundaries of the Boc-carbamate motif during extended storage

The compound exhibits thermal stability up to 140 °C by differential scanning calorimetry (DSC) at a ramp rate of 10 °C/min under nitrogen, with a sharp endothermic melting event at 78–80 °C. Isothermal thermogravimetric analysis (TGA) at 60 °C for 24 h shows mass loss below 0.15%, confirming that standard drying under vacuum at 40 °C and 10 mbar does not provoke premature deprotection. However, the Boc group is susceptible to acid-catalyzed cleavage; exposure to headspace carbon dioxide in poorly sealed polyethylene liners at ambient humidity generates trace carbonic acid, which has been observed to reduce N-Boc integrity by 0.3–0.7% over a 12-month storage period at 25 °C/60% RH. Consequently, double-bagging in low-density polyethylene with an intermediate desiccant pouch (silica gel, 50 g per 5 kg product) and an outer aluminium barrier laminate is specified. Under these conditions, re-test dating at 24 months is assigned per ICH Q1A(R2) long-term protocol.



Differences between this N-Boc-(S)-pyrrolidine alcohol and its N-Cbz or N-Fmoc analogues are most apparent in the deprotection orthogonality and the crystallization behavior of the resulting unprotected amino alcohol. N-Benzyloxycarbonyl (Cbz) removal by hydrogenolysis over 10% Pd/C at 1 atm H2 also reduces the heterocycle under forcing conditions, generating pyrrolidine ring-opened by-products, whereas the Boc group is cleaved cleanly with trifluoroacetic acid in dichloromethane at 0–25 °C or with 3 M HCl in cyclopentyl methyl ether, leaving the hydroxymethyl substituent intact. The N-Fmoc variant, while orthogonal to Boc in solid-phase peptide synthesis, introduces a dibenzofulvene scavenger stream that complicates post-reaction workup on multi-kilo scale. From a crystallization standpoint, the Boc derivative delivers a more favorable aspect ratio of needle-like crystals (5:1 length-to-width) compared to the plate-like habit of the Cbz congener, enabling faster filtration on an agitated Nutsche filter-dryer with PTFE cloth porosity 10 µm.


Specification profile for (S)-tert-butyl 3-(hydroxymethyl)pyrrolidine-1-carboxylate, pharmaceutical intermediate grade
Parameter
Method
Acceptance Criterion
Appearance
Visual (against white background)
White to off-white crystalline powder
Identification
FTIR-ATR (diamond crystal, 4000–400 cm⁻¹)
Conforms to reference spectrum; characteristic C=O stretch at 1680–1700 cm⁻¹
Assay (anhydrous, solvent-free)
HPLC (C18, 5 µm, 150 × 4.6 mm; isocratic acetonitrile/water 40:60; 1.0 mL/min, 210 nm)
≥98.0% area
Enantiomeric excess
Chiral HPLC (Chiralpak IA-3, n-hexane/2-propanol 90:10, 1.0 mL/min, 214 nm)
≥99.0% ee
Water content
Karl Fischer coulometric (oven method, 140 °C)
≤0.5%
Residual solvents
Headspace GC-FID (DB-624 column, 30 m × 0.53 mm, film thickness 3.0 µm)
Ethyl acetate ≤5000 ppm, n-heptane ≤5000 ppm, dichloromethane ≤600 ppm, methanol ≤3000 ppm
Residue on ignition
USP <281> (600 °C, 2 h)
≤0.1%
Heavy metals
ICP-MS (after microwave digestion, internal standard Rh)
Pd ≤10 ppm, Fe ≤20 ppm, Zn ≤10 ppm, total others ≤50 ppm
Melting range
USP <741> (capillary, ramp 1 °C/min)
77–81 °C





In the context of chiral amine synthesis for central nervous system drug candidates, the (S)-hydroxymethyl pyrrolidine scaffold has been employed to construct muscarinic M1 receptor positive allosteric modulators. The primary hydroxyl group is activated as the methanesulfonate ester using methanesulfonyl chloride in dichloromethane with triethylamine at −10 °C, then displaced with sodium azide in DMF at 80 °C to yield the corresponding (R)-azidomethyl derivative with inversion, an intermediate that resists racemization when the Boc group remains intact. Process safety evaluations for this sequence require calorimetric data: the mesylation exotherm measured by RC1e reaction calorimetry in a 2 L Mettler-Toledo reactor shows a heat release rate of 45 W/kg and an adiabatic temperature rise of 32 K, well within the cooling capacity of a standard −20 °C brine jacket. By contrast, the azide displacement step demands thorough hazard analysis because the organic azide intermediate generated in situ carries a thermal decomposition onset of 168 °C (DSC, 5 °C/min), necessitating dilution to ≤15 wt% in DMF and strict adherence to a maximum process temperature of 100 °C—a 68 °C margin recognized in CHETAH thermodynamic stability screening.

When the (R)-enantiomer is co-isolated from the mother liquors of a classical resolution, what impurity profile differences emerge?

Classical resolution with (R)-mandelic acid in isopropanol/water mixtures yields the (S)-alcohol as the less soluble diastereomeric salt, while the mother liquors are enriched in the (R)-enantiomer. The (R)-form retains an identical molecular weight and functional group inventory, yet its specific rotation is [α]D20 +29.5° (c = 1.0, methanol). Residual (R)-mandelic acid detected by ion-pair HPLC (tetrabutylammonium phosphate, pH 6.0) at levels as low as 0.05% w/w can catalyze transesterification when the alcohol is used as a nucleophile in Mitsunobu couplings with carboxylic acids, generating mandelate ester impurities that persist through final API crystallizations unless a dilute sodium bicarbonate wash is implemented prior to the coupling step. This divergent impurity propagation underscores the preference for enzymatic resolution, where the chiral selector is removed by simple filtration of the immobilized biocatalyst, leaving an aqueous buffer stream that is completely removed during extractive workup.

Bulk dried product is typically milled through a FitzMill L1A with a 0.020-inch round-hole screen, hammer forward, at 7000 rpm, to produce a particle size distribution with Dv90 < 150 µm. This particle engineering step reduces inter-particle void variation during automated drum charging and permits reproducible flow through a gravimetric loss-in-weight feeder (Brabender FlexWall® Plus FW40) calibrated to 2.5 kg/h when the compound is used as a solid feed in a continuous flow hydrogenation screening platform (H-Cube® Pro with a 30 mm CatCart® catalyst cartridge). In such a configuration, post-deblocking hydrogenation of the crude pyrrolidine stream over Raney nickel at 50 bar and 60 °C yields the saturated secondary amine in quantitative conversion, provided the feedstock is free of sulfur-containing stabilizers that poison the nickel surface.


Comparative analysis: (S)-tert-butyl 3-(hydroxymethyl)pyrrolidine-1-carboxylate versus close structural analogs
Compound
Protecting group
Chiral center position
Typical ee availability
Primary deprotection method
Crystallization solvent
(S)-tert-butyl 3-(hydroxymethyl)pyrrolidine-1-carboxylate
Boc
3
≥99.0%
TFA/CH₂Cl₂ or HCl/dioxane
MTBE/n-heptane
(R)-tert-butyl 3-(hydroxymethyl)pyrrolidine-1-carboxylate
Boc
3
≥98.5%
TFA/CH₂Cl₂
Ethyl acetate/hexanes
tert-butyl 3-(aminomethyl)pyrrolidine-1-carboxylate
Boc
Racemic
N/A
TFA/CH₂Cl₂
Acetonitrile/water
(S)-benzyl 3-(hydroxymethyl)pyrrolidine-1-carboxylate
Cbz
3
≥97.0%
H₂, Pd/C (risk of ring reduction)
Dichloromethane/heptane
(S)-tert-butyl 3-(hydroxymethyl)pyrrolidine-1-carboxylate (Fmoc analogue)
Fmoc
3
≥99.0%
20% piperidine/DMF
THF/water





The role of the hydroxymethyl handle in late-stage functionalization distinguishes this intermediate from the corresponding 3-aminomethyl or 3-carboxy entities. The alcohol avoids the acylation side reactions that plague free amines during palladium-catalyzed Buchwald–Hartwig couplings under basic conditions, and it does not require the in situ ester activation needed for amide bond formation with the carboxylic acid analogue. In one documented sequence, the unprotected alcohol is converted directly to the iodide (I₂, PPh₃, imidazole, CH₂Cl₂, 0 °C to rt) in 92% isolated yield without erosion of ee, a transformation that lays the groundwork for Negishi cross-coupling with organozinc reagents in the construction of sp3-rich drug-like libraries. The (S)-absolute configuration places the substituent in the proper spatial orientation to mimic the ethylamine side chain of endogenous neurotransmitters when the pyrrolidine nitrogen is deprotected and subsequently alkylated with aryl ethyl ketones under reductive amination conditions (NaBH(OAc)₃, 1,2-dichloroethane, 25 °C).

For regulated starting materials destined for GMP intermediate production, a validated analytical method package is maintained. The HPLC purity method demonstrates linearity over 0.05–2.0 mg/mL (R² = 0.9998) with a limit of quantitation for the des-Boc analog of 0.02%. Chiral method robustness was confirmed through a fractional factorial design varying column temperature (25–35 °C), flow rate (0.8–1.2 mL/min), and mobile phase composition (±2% n-hexane), with resolution between enantiomers remaining above 2.5 in all runs. A forced degradation study in 0.1 M HCl at 60 °C over 6 h revealed the primary degradation product as 3-(hydroxymethyl)pyrrolidine hydrochloride, which elutes at relative retention time 0.42 on the C18 system and does not interfere with the main peak.

Stability indicating storage conditions were established from accelerated aging at 40 °C/75% RH (open dish) over 6 months: total impurities increased from 0.15% to 0.42%, with the main rise attributed to the N-Boc deprotected amino alcohol. No increase in the (R)-enantiomer was observed, demonstrating configurational stability of the stereogenic center under thermal stress in the solid state. This configurational robustness persists even in solution in methanol or DMSO at 25 °C for 48 h, making the compound suitable as a stock solution in automated parallel synthesis platforms that utilize a 12-channel MicroLab® dispenser, where pre-dissolved building blocks are stored under inert atmosphere for multi-day campaigns.

When compared to the corresponding 2-hydroxymethyl isomer, the 3-substitution pattern on the pyrrolidine ring introduces a different vector angle for the pendant hydroxyl, which in turn alters the dihedral angle in the bound conformation of the final target molecule. Molecular mechanics calculations (MMFF94s) predict a C3–CH2OH dihedral of +60° relative to the plane of the pyrrolidine nitrogen in the lowest-energy conformer, whereas the 2-substituted isomer forces a near-eclipsed arrangement with the endocyclic C-N bond, increasing the barrier to rotation and restricting the accessible conformational space in pharmacophore models. This electronic and steric nuance has led medicinal chemistry groups to favor the 3-substituted scaffold for the construction of constrained tertiary amines targeting the histamine H3 receptor, where the N-Boc intermediate is carried through a parallel synthesis of 30–50 analogues using a Biotage® Initiator+ microwave synthesizer at 120 °C for 20 min.